期刊文献+

耐亚胺培南肺炎克雷伯菌耐药基因的检测分析

Detection and analysis of Klebsiella resistance gene in imipenem-resistant pneumonia
下载PDF
导出
摘要 目的分析耐亚胺培南肺炎克雷伯耐药基因检测效果,并对耐药机制进行分析。方法选取近3年分离出的260株耐亚胺培南肺炎克雷伯菌,采用新型耐药基因检查方法,对药物浓度进行分析。结果 Hodge检查结果显示,260株耐亚胺培南肺炎克雷伯菌中240株检查结果为阳性,20株为阴性,阳性率为92.3%。对β-内酰胺酶基因分析显示,有225株耐亚胺培南肺炎克雷伯菌产生KPC-2型碳青霉烯酶,其余耐亚胺培南肺炎克雷伯菌扩增出SHV型β-内酰胺酶基因。结论耐亚胺培南肺炎克雷伯菌的衍生因素比较复杂,在实践阶段需要做好耐药基因检查工作,只有做好检测工作,才能确定病菌类型。 Objective To analyze the detection effect of Klebsiella resistance gene in imipenem-resistantpneumonia.Methods In this study,260strains of Klebsiella pneumoniae were selected as the research object,andthe drug concentrations were analyzed by the new drug resistance method.Results The results of Hodge examinationshowed that240cases inhibited positive results and20cases inhibited negative results and the positiverate was92.3%.β-lactamase gene analysis showed that225strains of imipenem-resistant Klebsiella pneumoniaeproduced KPC-2carbapenemase,and others could amplify SHV typeβ-lactamase gene.Conclusion The factorsof resistance to imipenem pneumonia Klebsiella were more complicated.In the practical stage need,drug resistancecheck work should be paid more attention.
作者 季艳艳 杨正贵 张宏艳 Yanyan JI;Zhenggui YANG;Hongyan ZHANG(Department of Clinical Laboratory, Panjiang Coal and Electricity Investment Holding Corporation General Hospital, Liupanshui 553536, China)
出处 《临床检验杂志(电子版)》 2017年第1期101-102,共2页 Clinical Laboratory Journal(Electronic Edition)
关键词 耐亚胺培南肺炎克雷伯菌 耐药性 基因检测 Imipenem-resistant pneumonia Klebsiella Drug resistance Gene detection
  • 相关文献

参考文献7

二级参考文献70

  • 1糜祖煌.铜绿假单胞菌耐药基因及其检测[J].现代实用医学,2004,16(9):558-560. 被引量:47
  • 2贾艳,孙长江,韩文瑜,何礼洋,杨洋.肺炎克雷伯菌研究进展[J].微生物学杂志,2006,26(5):75-78. 被引量:49
  • 3冯福英,张亚彬,苏丽萍,王德春,黄晓辉.革兰阴性杆菌菌种分布及耐药性和分子流行病学研究[J].实用医学杂志,2006,22(24):2915-2917. 被引量:4
  • 4Yan J J, Ko WC, Tsai SH, et al. Outbreak of infection with multidrug- resistant Klebsiella pneumoniae carrying blaimp-8 in a university medical center in Taiwan[J]. J Clin Microbiol, 2001,39(12) :4433-4439.
  • 5Queenan AM,Bush K. Carbapenemases:the vrsatile β-Lacta- mases[J]. Clinical Microbiology Reviews, 2007,20 (3) : 446.
  • 6Leavitt A, Navon-Venezia S, Chmelnitsky I, et al. Emergence of KPC-2 and KPC-3 in earbapenem- resistant Klebsiella pneumoniae strains in an Israeli hospital [J]. Antimierob- Agents Chemother, 2007,51(8) : 3026-3029.
  • 7Navon-Venezia S, Leavitt A, Mitchell J, et al. Report on a hypere-pidemic clone of KPC-3-producing Klebsiella pneumoniae in Israel genetically related to a strain causing out-breaks in the United States[J]. Antimicrobial Agents and Chemotherapy, 2009,53 (2) : 818-820.
  • 8Leavitt A, Chmelnitsky I, Colodner R, et al. Ertapenem resistance among extended-spectrum-β-lactamase-producing Klebsiella pneumoniae isolates [J]. Clinical Microbiology 2009,47(4) :969-974.
  • 9Coudron PE, Moland ES, Thomson KS. Occurrence and de tection of AmpC beta lactamase among escherichia coli ,kleb siella pnemoniae, and proteus mirabilis isolates at a veterans medical center[J]. J Clin Microbiol,2000,38(5):1971-1976.
  • 10Philippon A,Arlet G,Jacoby GA. Plamid-determined AmpC- type beta lactamases[J]. Antimicrob Agent Chemother, 2002,46(1):1-11.

共引文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部